drugset / Trial / NCT06387212
35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin
NaSingle-groupOpen-labelTreatment
Summary
To explore the clinical effect and safety of 35 kDa hyaluronic acid fragment ( HA35 ) combined with negative pressure microneedle technology in improving skin problems.
Timeline
- Start
- 2024-04-15
- Primary completion
- 2024-05
- Completion
- 2024-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 35 kDa hyaluronan fragment | Unknown | — | Subcutaneous |